1. Home
  2. TMCI vs NVRI Comparison

TMCI vs NVRI Comparison

Compare TMCI & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • NVRI
  • Stock Information
  • Founded
  • TMCI 2014
  • NVRI 1853
  • Country
  • TMCI United States
  • NVRI United States
  • Employees
  • TMCI N/A
  • NVRI N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NVRI Diversified Commercial Services
  • Sector
  • TMCI Health Care
  • NVRI Miscellaneous
  • Exchange
  • TMCI Nasdaq
  • NVRI Nasdaq
  • Market Cap
  • TMCI 460.5M
  • NVRI 521.3M
  • IPO Year
  • TMCI 2021
  • NVRI N/A
  • Fundamental
  • Price
  • TMCI $5.74
  • NVRI $8.22
  • Analyst Decision
  • TMCI Hold
  • NVRI Hold
  • Analyst Count
  • TMCI 6
  • NVRI 1
  • Target Price
  • TMCI $9.18
  • NVRI $10.00
  • AVG Volume (30 Days)
  • TMCI 554.1K
  • NVRI 774.0K
  • Earning Date
  • TMCI 05-08-2025
  • NVRI 05-01-2025
  • Dividend Yield
  • TMCI N/A
  • NVRI N/A
  • EPS Growth
  • TMCI N/A
  • NVRI N/A
  • EPS
  • TMCI N/A
  • NVRI N/A
  • Revenue
  • TMCI $210,819,000.00
  • NVRI $2,290,612,000.00
  • Revenue This Year
  • TMCI $10.61
  • NVRI $0.02
  • Revenue Next Year
  • TMCI $10.36
  • NVRI $3.71
  • P/E Ratio
  • TMCI N/A
  • NVRI N/A
  • Revenue Growth
  • TMCI 7.54
  • NVRI N/A
  • 52 Week Low
  • TMCI $4.54
  • NVRI $4.72
  • 52 Week High
  • TMCI $10.79
  • NVRI $12.79
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 30.94
  • NVRI 68.30
  • Support Level
  • TMCI $5.70
  • NVRI $7.35
  • Resistance Level
  • TMCI $6.20
  • NVRI $8.27
  • Average True Range (ATR)
  • TMCI 0.37
  • NVRI 0.29
  • MACD
  • TMCI -0.08
  • NVRI 0.03
  • Stochastic Oscillator
  • TMCI 2.04
  • NVRI 85.78

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

Share on Social Networks: